Dosidal · Belgium

Xanthium - 400 400 mg

Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.

MarketBelgium
Recordbe:presentation:cti:138564-03 (version 1)
Levelpresentation
Pack codenot anchored
Identifiersbe-cti-extended: 138564-03
be-authorisation: BE138564
Source authorityFAMHP
Read date2026-11-15T03:58:09Z
authorisation statusamp_status: AUTHORIZED
ampp_status: AUTHORIZED
commercialised_now: False
lifecycle: current
period_from: 2025-03-03
supply_problem_now: False
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
controlled status
state: unknown
identityamp_code: SAM138564-00
atc: R03DA04
authorisation_number: BE138564
cti_extended: 138564-03
form: Prolonged-release capsule, hard
holder: Laboratoires S.M.B.
medicine_type: ALLOPATHIC
name: Xanthium - 400 400 mg
pack: 100 (100 x 1)
parallel_circuit: 0
parallel_import: False
substances: substance: Theophylline Monohydrate
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
pack product codefmd_in_scope: True
note: no FMD product code and no CNK in SAM
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
prescription classas_published: Medical prescription - Art 6, §1 bis, 2nd paragraph, 1st indent Law 25/03/1964 + Art 61 Royal Decree 14/12/2006
class: prescription
delivery_modus: M1
state: current · read 2026-11-15T03:58:09Z · source: SAM v2 (FAMHP, NIHDI, BCFI; Smals) page
SignatureES256 over JCS, key dosidal-record-1.9dbf5d53
avXJ_zlphGklkKbVpVjBS7JApV0okYL__VWy1OydLieekFV3oB-fPXAjR7_Q4EU69wuYAo8nb5_Len02ZZVzPg
Verify with verify_record (MCP) or POST https://dosidal-api.ai/v1/verify/record; keyring https://dosidal-registry.ai/.well-known/jwks.json

JSON: https://dosidal-api.ai/v1/records/be:presentation:cti:138564-03 · Related records in other markets · Dosidal